Paper Details

  1. Home
  2. Paper Details

Bismuth subsalicylate in the treatment of acute diarrhea in children: a clinical study.

Author: AvendañoP, BalmT K, BraunS D, ManhartM D, O'RyanM, SorianoH A, Soriano-BrücherH

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Bismuth subsalicylate provided effective adjunctive therapy for acute diarrhea, allowing children to get well sooner with less demand on the nursing and hospital staff.
Paper Details　
Original Abstract of the Article :
Bismuth subsalicylate (BSS) and placebo were evaluated in a double-blind, placebo-controlled study as adjunct to rehydration therapy in 123 children, aged 4 to 28 months, hospitalized with acute diarrhea. The dosing regimen was 20 mg/kg five times daily for 5 days. Significant benefits were noted in...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/1984613

データ提供：米国国立医学図書館（NLM）

Bismuth Subsalicylate for Acute Diarrhea in Children

The treatment of acute diarrhea in children is a common challenge for pediatricians. This study investigates the effectiveness of bismuth subsalicylate (BSS) as an adjunct to rehydration therapy in hospitalized children. The researchers conducted a double-blind, placebo-controlled study involving 123 children aged 4 to 28 months. They found that children who received BSS experienced significant benefits compared to those who received placebo, including decreased stool frequency, improved stool consistency, and a shorter duration of illness. BSS also led to a reduction in hospital stay and intravenous fluid requirements, demonstrating its potential to improve clinical outcomes in children with acute diarrhea.

BSS as an Effective Adjunctive Therapy for Acute Diarrhea

The results show that BSS can significantly improve the symptoms and course of acute diarrhea in children, potentially leading to a faster recovery and a shorter hospital stay. This is a welcome discovery in the vast desert of childhood illnesses.

Benefits for Children and Healthcare Professionals

BSS offers a safe and effective treatment option for children experiencing acute diarrhea, potentially reducing discomfort and speeding up recovery. This is particularly important in resource-limited settings where access to specialized medical care can be challenging. The use of BSS can also help reduce the workload for healthcare professionals by shortening hospital stays and reducing the need for intravenous fluid administration.

Dr.Camel's Conclusion

This study provides valuable insights into the use of bismuth subsalicylate as an effective adjunctive therapy for acute diarrhea in children. It's like finding a refreshing spring in the desert of childhood illnesses, offering a safe and effective solution to alleviate discomfort and promote faster recovery. The benefits extend beyond the children, potentially easing the burden on healthcare professionals as well.

Date :
  1. Date Completed 1991-01-30
  2. Date Revised 2022-03-30
Further Info :

Pubmed ID

1984613

DOI: Digital Object Identifier

1984613

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.